• In early May 2026, DXC Technology reported fourth-quarter and full-year 2026 results showing lower sales and a swing from prior-year profit to a US$141 million quarterly net loss, alongside muted full-year earnings of US$18 million on slightly lower annual revenue of US$12.64 billion.
• At the same time, DXC intensified its AI-led repositioning with the launch of its OASIS orchestration platform and completed a large multi-year share buyback, even as a law firm opened a securities investigation into the company’s disclosures and operational execution.
• We’ll now explore how DXC’s weaker earnings outlook, combined with its AI-focused OASIS launch, reshapes the earlier investment narrative.

We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

DXC Technology Investment Narrative Recap

To own DXC today, you need to believe its AI-led pivot can eventually offset shrinking legacy IT work and recent profit pressure. The latest quarter’s small revenue dip and swing to a US$141 million loss sharpen the near term focus on whether AI products and execution can stabilize bookings. The key near term catalyst is proof that new AI services can translate into healthier revenue mix, while a major risk is continued earnings volatility and weak guidance undermining confidence.

The launch of DXC OASIS goes right to the heart of that catalyst, because it is framed as an AI-first orchestration layer for complex, multivendor estates rather than just another outsourcing offer. For investors, OASIS connects directly to the question of whether DXC can reposition itself toward higher value, AI enabled managed services that support margins, even as legacy infrastructure revenues remain under pressure and the company faces an ongoing securities investigation into its disclosures.

Yet alongside this AI story, investors should also be aware of the risk that prolonged revenue declines and shrinking demand for legacy services could...

DXC Technology's narrative projects $12.1 billion revenue and $208.6 million earnings by 2028. This implies a 1.7% yearly revenue decline and an earnings decrease of $170.4 million from $379.0 million today.

Uncover how DXC Technology's forecasts yield a $14.50 fair value, a 63% upside to its current price.

Exploring Other Perspectives

Before this reset, the most optimistic analysts were still assuming modest revenue erosion to about US$12.2 billion and earnings near US$85.7 million, which is a far more upbeat take than the current guidance and highlights how differently you and other shareholders might weigh contract wins versus execution risks once these new results are fully reflected.

Explore 3 other fair value estimates on DXC Technology - why the stock might be worth over 3x more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DXC Technology research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free DXC Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DXC Technology's overall financial health at a glance.

Searching For A Fresh Perspective?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.